With so many Western firms either expanding operations in China or looking to invest in that country's emerging biotech market, we sought the insights of someone with an insider's view of that market. This week, BioCommerce Week interviewed Matthew Chervenak, CEO of General Biologic, a Shanghai-based consultancy with 10 employees, about the opportunities and challenges companies face when they enter the Chinese market. Chervenak started the business about three years ago after working as both a scientist and as a strategy consultant in the US.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.